NCT02503254View on ClinicalTrials.gov

Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement.

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

March 31, 2016

Conditions
Smoking
Interventions
OTHER

CHTP 1.0

CHTP 1.0 ad libitum for 5 days in confinement

OTHER

Conventional Cigarette (CC)

Subject's own preferred brand of CC ad libitum for 5 days in confinement

Trial Locations (1)

05-830

BioVirtus Research Site Sp. z o.o., Kajetany

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY

NCT02503254 - Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement. | Biotech Hunter | Biotech Hunter